Novo Nordisk said it expects weaker sales growth of its popular weight-loss drug Wegovy due to competition from copycat drugs ...

Shares in Wegovy maker Novo Nordisk continued to slide on Wednesday as analysts warned of persistent competition from copycat ...

There's no better drive-thru porch-sipper than McDonald's Sweet Tea, but you can brew a copycat version with plenty of sugar ...

The pharmaceutical giant said multiple entities were still marketing and selling unbranded versions of its drug despite U.S.

Furthermore, the governments called out Scattered Spider's use of readily available malware tools like Ave Maria (aka Warzone ...

“NCIS: Tony & Ziva” star Cote de Pablo reveals why she and Michael Weatherly didn't want an intimacy coordinator Pete Buttigieg says Democratic Party’s attachment to two words handed Trump the White ...

Shares in the maker of Ozempic crashed to three-year low after the pharma giant warned its injections were losing ground to ...

If all we learn is how to mouth a buzzword and keep it handy for use in soundbites, we’ve failed the very voters we claim to ...

The Danish firm blamed the move to slash its guidance on intense competition from rivals and copycat drugs in the US.

Novo Nordisk's new CEO Maziar Mike Doustdar has been handed the reins to turn around the Wegovy-making firm's flagging sales ...